Living a Life on Purpose: A Conversation with Dr. Randy

 

When people take stock of their lives, do they consider their accomplishments remarkable? Or is the word remarkable reserved only for those with unique talents and wondrous deeds? Maybe remarkable isn’t a word others use to describe a person; perhaps it’s a code to live by. Today, I choose to be Remarkable! Capitalize that R and add an exclamation point to it. That mantra comes from a man who made it his mission to live his life on purpose. To be remarkable, Dr. Randy Ross says, choose to be Remarkable!

Inspiring and influencing others is a key differentiator in leadership, and motivating teams can make a good organization great. Dr. Randy Ross is a bestselling author and CEO of Remarkable. He brings his dynamic communication approach to organizations such as Delta, Chick-fil-A, McDonald’s, Panasonic, and more to help strengthen team development and organizational health.

Ross spoke with I Don’t Care’s Kevin Stevenson about his career and his love for working with organizations and leadership to improve them. Ross, a pastor for many years, felt a new calling the more he worked with business leaders.

“I fell in love with the boardroom,” Ross said. “I felt called into corporate circles because I saw this interesting disparity, this paradox if you will; so many organizations struggled to embrace this idea of culture in a profound way. They knew the importance of it, but they didn’t know how to craft it.”

Stevenson and Ross discuss the following:

  • Connecting personal passion with corporate objectives
  • The concept of “anchored by hope”
  • Ross’s book Relationomics

“I wanted to write a book that would be a practical ‘how to,’” Dr. Ross said. “We kind of built the framework for the principals, but now how do you do this? How do you put it into practice? So, Relationomics is a book I wrote for managers and anybody who gives oversight to others. And it is a lot of practical things that you and I might say is common sense, but I can assure you it is not always common practice.”

About Randy:

Dr. Randy Ross is the bestselling author of multiple books, including Relationomics: Business Powered by Relationships, Remarkable!, and Hope Rises: Making Your Life, Love & Leadership Soar. Ross works with known brands to inspire and enable countless people to find new passion and purpose in their work, work better together in teams, and have more significant influence and impact. He holds a B.A. in Philosophy and Religion from Baylor University and a Doctorate from Southwestern Baptist Theological Seminary.

Follow us on social media for the latest updates in B2B!

Image

Latest

vitro
Analyzing the Suppressive TME in In Vitro Based Assays
April 19, 2025

In the rapidly advancing field of cancer immunotherapy, accurately modeling the tumor microenvironment (TME) has become essential to improving the predictive power of preclinical drug testing. As immune-modulating therapies surge forward, with over 4,000 immune modulators in development globally, scientists are refining assay technologies that maintain the complexity of patient-specific tumor biology. In vitro platforms…

Read More
cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More